Cargando…

CD19 and CD20 Targeted Vectors Induce Minimal Activation of Resting B Lymphocytes

B lymphocytes are an important cell population of the immune system. However, until recently it was not possible to transduce resting B lymphocytes with retro- or lentiviral vectors, making them unsusceptible for genetic manipulations by these vectors. Lately, we demonstrated that lentiviral vectors...

Descripción completa

Detalles Bibliográficos
Autores principales: Kneissl, Sabrina, Zhou, Qi, Schwenkert, Michael, Cosset, François-Loic, Verhoeyen, Els, Buchholz, Christian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823979/
https://www.ncbi.nlm.nih.gov/pubmed/24244415
http://dx.doi.org/10.1371/journal.pone.0079047
_version_ 1782290644468760576
author Kneissl, Sabrina
Zhou, Qi
Schwenkert, Michael
Cosset, François-Loic
Verhoeyen, Els
Buchholz, Christian J.
author_facet Kneissl, Sabrina
Zhou, Qi
Schwenkert, Michael
Cosset, François-Loic
Verhoeyen, Els
Buchholz, Christian J.
author_sort Kneissl, Sabrina
collection PubMed
description B lymphocytes are an important cell population of the immune system. However, until recently it was not possible to transduce resting B lymphocytes with retro- or lentiviral vectors, making them unsusceptible for genetic manipulations by these vectors. Lately, we demonstrated that lentiviral vectors pseudotyped with modified measles virus (MV) glycoproteins hemagglutinin, responsible for receptor recognition, and fusion protein were able to overcome this transduction block. They use either the natural MV receptors, CD46 and signaling lymphocyte activation molecule (SLAM), for cell entry (MV-LV) or the vector particles were further modified to selectively enter via the CD20 molecule, which is exclusively expressed on B lymphocytes (CD20-LV). It has been shown previously that transduction by MV-LV does not induce B lymphocyte activation. However, if this is also true for CD20-LV is still unknown. Here, we generated a vector specific for another B lymphocyte marker, CD19, and compared its ability to transduce resting B lymphocytes with CD20-LV. The vector (CD19ds-LV) was able to stably transduce unstimulated B lymphocytes, albeit with a reduced efficiency of about 10% compared to CD20-LV, which transduced about 30% of the cells. Since CD20 as well as CD19 are closely linked to the B lymphocyte activation pathway, we investigated if engagement of CD20 or CD19 molecules by the vector particles induces activating stimuli in resting B lymphocytes. Although, activation of B lymphocytes often involves calcium influx, we did not detect elevated calcium levels. However, the activation marker CD71 was substantially up-regulated upon CD20-LV transduction and most importantly, B lymphocytes transduced with CD20-LV or CD19ds-LV entered the G1b phase of cell cycle, whereas untransduced or MV-LV transduced B lymphocytes remained in G0. Hence, CD20 and CD19 targeting vectors induce activating stimuli in resting B lymphocytes, which most likely renders them susceptible for lentiviral vector transduction.
format Online
Article
Text
id pubmed-3823979
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38239792013-11-15 CD19 and CD20 Targeted Vectors Induce Minimal Activation of Resting B Lymphocytes Kneissl, Sabrina Zhou, Qi Schwenkert, Michael Cosset, François-Loic Verhoeyen, Els Buchholz, Christian J. PLoS One Research Article B lymphocytes are an important cell population of the immune system. However, until recently it was not possible to transduce resting B lymphocytes with retro- or lentiviral vectors, making them unsusceptible for genetic manipulations by these vectors. Lately, we demonstrated that lentiviral vectors pseudotyped with modified measles virus (MV) glycoproteins hemagglutinin, responsible for receptor recognition, and fusion protein were able to overcome this transduction block. They use either the natural MV receptors, CD46 and signaling lymphocyte activation molecule (SLAM), for cell entry (MV-LV) or the vector particles were further modified to selectively enter via the CD20 molecule, which is exclusively expressed on B lymphocytes (CD20-LV). It has been shown previously that transduction by MV-LV does not induce B lymphocyte activation. However, if this is also true for CD20-LV is still unknown. Here, we generated a vector specific for another B lymphocyte marker, CD19, and compared its ability to transduce resting B lymphocytes with CD20-LV. The vector (CD19ds-LV) was able to stably transduce unstimulated B lymphocytes, albeit with a reduced efficiency of about 10% compared to CD20-LV, which transduced about 30% of the cells. Since CD20 as well as CD19 are closely linked to the B lymphocyte activation pathway, we investigated if engagement of CD20 or CD19 molecules by the vector particles induces activating stimuli in resting B lymphocytes. Although, activation of B lymphocytes often involves calcium influx, we did not detect elevated calcium levels. However, the activation marker CD71 was substantially up-regulated upon CD20-LV transduction and most importantly, B lymphocytes transduced with CD20-LV or CD19ds-LV entered the G1b phase of cell cycle, whereas untransduced or MV-LV transduced B lymphocytes remained in G0. Hence, CD20 and CD19 targeting vectors induce activating stimuli in resting B lymphocytes, which most likely renders them susceptible for lentiviral vector transduction. Public Library of Science 2013-11-11 /pmc/articles/PMC3823979/ /pubmed/24244415 http://dx.doi.org/10.1371/journal.pone.0079047 Text en © 2013 Kneissl et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Kneissl, Sabrina
Zhou, Qi
Schwenkert, Michael
Cosset, François-Loic
Verhoeyen, Els
Buchholz, Christian J.
CD19 and CD20 Targeted Vectors Induce Minimal Activation of Resting B Lymphocytes
title CD19 and CD20 Targeted Vectors Induce Minimal Activation of Resting B Lymphocytes
title_full CD19 and CD20 Targeted Vectors Induce Minimal Activation of Resting B Lymphocytes
title_fullStr CD19 and CD20 Targeted Vectors Induce Minimal Activation of Resting B Lymphocytes
title_full_unstemmed CD19 and CD20 Targeted Vectors Induce Minimal Activation of Resting B Lymphocytes
title_short CD19 and CD20 Targeted Vectors Induce Minimal Activation of Resting B Lymphocytes
title_sort cd19 and cd20 targeted vectors induce minimal activation of resting b lymphocytes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823979/
https://www.ncbi.nlm.nih.gov/pubmed/24244415
http://dx.doi.org/10.1371/journal.pone.0079047
work_keys_str_mv AT kneisslsabrina cd19andcd20targetedvectorsinduceminimalactivationofrestingblymphocytes
AT zhouqi cd19andcd20targetedvectorsinduceminimalactivationofrestingblymphocytes
AT schwenkertmichael cd19andcd20targetedvectorsinduceminimalactivationofrestingblymphocytes
AT cossetfrancoisloic cd19andcd20targetedvectorsinduceminimalactivationofrestingblymphocytes
AT verhoeyenels cd19andcd20targetedvectorsinduceminimalactivationofrestingblymphocytes
AT buchholzchristianj cd19andcd20targetedvectorsinduceminimalactivationofrestingblymphocytes